CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 27 enrolled
Drug / intervention
connective tissue autograft +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01431144
NCT01431144N/ACompleted
CompareCT.gov

The Effect of Implant Placement and Simultaneous Soft Tissue Augmentation in the Esthetic Zone Using Either Connective Tissue Autograft or Acellular Dermal Matrix Allograft on Peri-implant Hard and Soft Tissue Healing

University of Louisville·interventional·Posted Sep 9, 2011·Updated Feb 1, 2017

In Brief

A clinical study evaluating connective tissue autograft and connective tissue allograft for Edentulous. Completed, enrolled 27 participants across 1 site.

Detailed Summary

This study is a comparison of implant placed and simultaneously grafted with either autogenous connective tissue or a connective tissue allograft. The objective is to determine the change in soft tissue thickness and determine if a better result is obtained with the autograft or the allograft. The hypothesis is that there will be no difference in soft tissue thickness over the implant between the autograft and the allograft technique.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEdentulous
CountriesUnited States
CollaboratorsBioHorizons, Inc.

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 9, 2011
Enrollment StartSep 1, 2011
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 14.8 years ago

Interventions

connective tissue autograftprocedure

A connective tissue autograft is harvested from the palate and grafted at the site of implant placement on the facial surface.

connective tissue allograftprocedure

An acellular dermal matrix allograft (Alloderm, BioHorizons, Inc, Birmingham, AL, USA) is grafted at the site of implant placement on the facial surface.